DCGI approves Bharat Biotech’s intranasal Covid booster dose trial in India 1 min read articles general DCGI approves Bharat Biotech’s intranasal Covid booster dose trial in India Patel 2 months ago The Drugs Controller General of India has given its approval to Bharat Biotech for trials of its intranasal Covid booster dose in India. The trial...Read More